M&A Deal Summary

Recordati Acquires Orphan Europe SARL

On September 28, 2007, Recordati acquired life science company Orphan Europe SARL for 135M EUR

Acquisition Highlights
  • This is Recordati’s 2nd transaction in the Life Science sector.
  • This is Recordati’s 0th largest (disclosed) transaction.
  • This is Recordati’s 3rd transaction in France.

M&A Deal Summary

Date 2007-09-28
Target Orphan Europe SARL
Sector Life Science
Buyer(s) Recordati
Deal Type Add-on Acquisition
Deal Value 135M EUR

Target

Orphan Europe SARL

Paris La Défense, France
Orphan Europe is a European pharmaceutical group specialized in rare diseases with headquarters in Paris. Orphan Europe is a European pharmaceutical company dedicated to the development, registration, marketing and distribution of unique drugs for the treatment of rare and orphan diseases.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Recordati

Milan, Italy

Category Company
Founded 1926
Sector Medical Products
Employees4,455
Revenue 2.1B EUR (2023)
DESCRIPTION

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.


DEAL STATS #
Overall 4 of 17
Sector (Life Science) 2 of 10
Type (Add-on Acquisition) 3 of 15
Country (France) 3 of 5
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-22 Merckle - Pharmaceutical Business

Ulm, Germany

Merckle GmbH - Pharmaceutical Business engages in the distribution and marketing of pharmaceutical products.

Buy €45M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-07 FIC Médical SARL

Puteaux, France

FIC Médical SARL company specializes in gynecology, hormonal treatments, ENT, gastroenterology, dermatology, and para-pharmacy.

Buy €12M